FDA Warns Florida Compounder for Failing to Meet Quality Conditions

Drug Industry Daily
A A
The FDA hit Hybrid Pharma with a warning letter, citing the Deerfield Beach, Florida, pharmacy for producing drugs that failed to qualify for exemptions from FDA oversight for compounded drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily